透析导管临床试验终点的推荐标准
血液透析中心静脉导管并发症频发,亟需新药或器械预防。多学科专家组提出导管相关血流感染、导管功能障碍和中心静脉阻塞的标准化定义,以指导未来临床试验设计并满足FDA审批要求。
要点
- 导管相关血流感染需临床怀疑感染且导管与外周血培养同菌,并排除其他感染源。
- 导管功能障碍定义为无法完成单次透析或连续两次血流量>300 ml/min或Kt/V≥1.2。
- 中心静脉阻塞疑诊需静脉造影示>70%狭窄、同侧上肢水肿及导管史。
核心结论
- 专家组提出了透析导管相关血流感染、导管功能障碍和中心静脉阻塞的标准化临床试验终点定义,以指导未来研究。
研究设计与样本
- 多学科专家组共识,未报告样本量或系统检索方法。
主要发现
- 导管相关血流感染需临床怀疑感染、导管与外周血培养同菌且无其他感染源证据。
- 导管功能障碍定义为无法完成单次透析或连续两次透析血流量>300 ml/min或Kt/V≥1.2且持续存在。
- 中心静脉阻塞疑诊需静脉造影示>70%狭窄、同侧上肢水肿及中心静脉导管史。
关键数值与推荐
- 导管相关血流感染:临床怀疑感染(发热、寒战、意识改变或不明原因低血压),导管与外周静脉(或透析管路)血培养同菌,且无其他感染源证据。
- 导管功能障碍:无法完成单次透析不触发反复压力报警,或连续两次透析血流量>300 ml/min(压力在透析机参数内),或4小时内Kt/V≥1.2;需尝试调整体位、反转管路或强力冲管后仍持续。
- 中心静脉阻塞疑诊:静脉造影示中心静脉>70%狭窄或等效,同侧上肢水肿,现有或既往中心静脉导管史。
临床怎么用
- 临床试验可采用这些标准化定义评估导管相关并发症的预防措施。
- 临床诊断导管相关血流感染需同时满足临床怀疑、血培养同菌及排除其他感染源。
- 导管功能障碍需在尝试调整后仍持续存在方可诊断。
局限性
- 专家组指出这些诊断的具体标准仍存在不确定性,并提出了未来高优先级研究以解决这些问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Central venous catheters are used frequently in patients on hemodialysis as a bridge to a permanent vascular access. They are prone to frequent complications, including catheter-related bloodstream infection, catheter dysfunction, and central vein obstruction. There is a compelling need to develop new drugs or devices to prevent central venous catheter complications. We convened a multidisciplinary panel of experts to propose standardized definitions of catheter end points to guide the design of future clinical trials seeking approval from the Food and Drug Administration. Our workgroup suggests diagnosing catheter-related bloodstream infection in catheter-dependent patients on hemodialysis with a clinical suspicion of infection (fever, rigors, altered mental status, or unexplained hypotension), blood cultures growing the same organism from the catheter hub and a peripheral vein (or the dialysis bloodline), and absence of evidence for an alternative source of infection. Catheter dysfunction is defined as the inability of a central venous catheter to (1) complete a single dialysis session without triggering recurrent pressure alarms or (2) reproducibly deliver a mean dialysis blood flow of >300 ml/min (with arterial and venous pressures being within the hemodialysis unit parameters) on two consecutive dialysis sessions or provide a Kt/V≥1.2 in 4 hours or less. Catheter dysfunction is defined only if it persists, despite attempts to reposition the patient, reverse the arterial and venous lines, or forcefully flush the catheter. Central vein obstruction is suspected in patients with >70% stenosis of a central vein by contrast venography or the equivalent, ipsilateral upper extremity edema, and an existing or prior history of a central venous catheter. There is some uncertainty about the specific criteria for these diagnoses, and the workgroup has also proposed future high-priority studies to resolve these questions.
引用
- Allon M, Brouwer-Maier DJ, Abreo K, et al. Recommended Clinical Trial End Points for Dialysis Catheters. Clin J Am Soc Nephrol. 2017. PMID: 28729382. doi:10.2215/CJN.12011116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。